IQV
IQVIA·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Strong Buy"
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About IQV
Iqvia Holdings Inc.
A global healthcare company that provides advanced analytics, technology solutions, and contract research services to the life sciences industry
Life Science Tools and Services
--
05/09/2013
New York Stock Exchange
88,000
12-31
Common stock
2400 Ellis Rd., Durham, North Carolina 27703
--
IQVIA Holdings Inc., is incorporated in Delaware. IQVIA is a leading global provider of clinical research services, business insights and healthcare intelligence to the life sciences and healthcare industries. The company is committed to accelerating the development and commercialization of Innovative Medical therapies to help improve patient outcomes and population health worldwide.
Earnings Call
Q1/2025
Estimate EPS2.63
Actual EPS2.7
Estimate Revenue3.77B
Actual Revenue3.83B
IQVIA's Q1 2025: Navigating Contradictory Signals on Growth, Partnerships, and Pricing
May 06,2025 08:22
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
IQV has released its 2025 Q3 earnings. EPS was reported at 3, versus the expected 2.98, beating expectations. The chart below visualizes how IQV has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
IQV has released its 2025 Q3 earnings report, with revenue of 4.10B, reflecting a YoY change of 5.24%, and net profit of 332.00M, showing a YoY change of 16.49%. The Sankey diagram below clearly presents IQV's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
